Merz Pharma invests in Cytrellis Biosystems
July 7th, 2016
Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing non-surgical products to combat sagging skin associated with aging. The investment emphasizes Merz’ strategy to allocate venture investment focused on the areas of anti-aging, skin rejuvenation and body shaping.
